1. Home
  2. AMRX vs JPC Comparison

AMRX vs JPC Comparison

Compare AMRX & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • JPC
  • Stock Information
  • Founded
  • AMRX 2002
  • JPC 2003
  • Country
  • AMRX United States
  • JPC United States
  • Employees
  • AMRX N/A
  • JPC N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • JPC Investment Managers
  • Sector
  • AMRX Health Care
  • JPC Finance
  • Exchange
  • AMRX Nasdaq
  • JPC Nasdaq
  • Market Cap
  • AMRX 2.7B
  • JPC 2.6B
  • IPO Year
  • AMRX N/A
  • JPC N/A
  • Fundamental
  • Price
  • AMRX $8.47
  • JPC $8.06
  • Analyst Decision
  • AMRX Strong Buy
  • JPC
  • Analyst Count
  • AMRX 5
  • JPC 0
  • Target Price
  • AMRX $10.00
  • JPC N/A
  • AVG Volume (30 Days)
  • AMRX 1.1M
  • JPC 998.5K
  • Earning Date
  • AMRX 11-08-2024
  • JPC 01-01-0001
  • Dividend Yield
  • AMRX N/A
  • JPC 7.57%
  • EPS Growth
  • AMRX N/A
  • JPC N/A
  • EPS
  • AMRX N/A
  • JPC N/A
  • Revenue
  • AMRX $2,680,420,000.00
  • JPC N/A
  • Revenue This Year
  • AMRX $17.56
  • JPC N/A
  • Revenue Next Year
  • AMRX $3.23
  • JPC N/A
  • P/E Ratio
  • AMRX N/A
  • JPC N/A
  • Revenue Growth
  • AMRX 12.32
  • JPC N/A
  • 52 Week Low
  • AMRX $4.16
  • JPC $5.94
  • 52 Week High
  • AMRX $9.48
  • JPC $7.36
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 45.78
  • JPC 45.71
  • Support Level
  • AMRX $7.52
  • JPC $8.03
  • Resistance Level
  • AMRX $9.48
  • JPC $8.12
  • Average True Range (ATR)
  • AMRX 0.35
  • JPC 0.07
  • MACD
  • AMRX 0.02
  • JPC -0.00
  • Stochastic Oscillator
  • AMRX 48.59
  • JPC 30.00

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About JPC Nuveen Preferred & Income Opportunities Fund

Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.

Share on Social Networks: